Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alfresa Holdings Corporation (JP:2784)
TSE/TYO:2784
Alfresa Holdings (2784) Stock Price & Analysis
0 Followers
2784 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥2,022.00 - ¥2,566.70
Previous Close¥2,199
Volume323.40K
Average Volume (3M)408.23K
Market Cap
¥445.01B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)14.3
Beta0.67
Next Earnings
Aug 06, 2024EPS Estimate
¥29.52Last Dividend Ex-Date
Mar 28, 2024Dividend Yield3.23%
Share Statistics
EPS (TTM)155.43
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume408,234
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥2,502.96Price Target Upside13.82% Upside
Rating ConsensusHold
Number of Analyst Covering1
Alfresa Holdings News
PremiumCompany Announcements
Alfresa Holdings Champions Enhanced Corporate GovernanceOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
3.18% Mutual Funds
4.99% Other Institutional Investors
91.84% Public Companies and
Individual Investors
2784 FAQ
What was Alfresa Holdings Corporation’s price range in the past 12 months?
Alfresa Holdings Corporation lowest stock price was ¥2022.00 and its highest was ¥2566.70 in the past 12 months.
What is Alfresa Holdings Corporation’s market cap?
Currently, no data Available
When is Alfresa Holdings Corporation’s upcoming earnings report date?
Alfresa Holdings Corporation’s upcoming earnings report date is Aug 06, 2024 which is in 35 days.
How were Alfresa Holdings Corporation’s earnings last quarter?
Alfresa Holdings Corporation released its earnings results on May 14, 2024. The company reported ¥46.487 earnings per share for the quarter, beating the consensus estimate of ¥38.317 by ¥8.17.
Is Alfresa Holdings Corporation overvalued?
According to Wall Street analysts Alfresa Holdings Corporation’s price is currently Undervalued.
Does Alfresa Holdings Corporation pay dividends?
Alfresa Holdings Corporation pays a Semiannually dividend of ¥5 which represents an annual dividend yield of 3.23%. See more information on Alfresa Holdings Corporation dividends here
What is Alfresa Holdings Corporation’s EPS estimate?
Alfresa Holdings Corporation’s EPS estimate is ¥29.52.
How many shares outstanding does Alfresa Holdings Corporation have?
Alfresa Holdings Corporation has 202,840,000 shares outstanding.
What happened to Alfresa Holdings Corporation’s price movement after its last earnings report?
Alfresa Holdings Corporation reported an EPS of ¥46.487 in its last earnings report, beating expectations of ¥38.317. Following the earnings report the stock price went down -1.796%.
Which hedge fund is a major shareholder of Alfresa Holdings Corporation?
Currently, no hedge funds are holding shares in JP:2784
---
Alfresa Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.98%
12-Months-Change
Fundamentals
Return on Equity
5.94%
Trailing 12-Months
Asset Growth
-4.99%
Trailing 12-Months
Company Description
Alfresa Holdings Corporation
Alfresa Holdings Corp. engages in the management of its subsidiaries that deal with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices. It operates through the following segments: Ethical Pharmaceuticals Wholesaling, Self-Medication Products Wholesaling, Manufacturing, and Medical-related. The Ethical Pharmaceuticals Wholesaling segment provides wholesale prescription drugs, medical diagnostic reagents, medical devices, equipment, and materials to hospitals, clinics, dispensing pharmacies, and other institutions. The Self-Medication Products Wholesaling segment sells over-the-counter drugs, health food, and supplements. The Manufacturing segment manufactures and markets pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices. The Medical-related segment offers medical services through its dispensing pharmacies. The company was founded on September 29, 2003 and is headquartered in Tokyo, Japan.
---
2784 Stock 12 Month Forecast
Average Price Target
¥2,502.96
▲(13.82% Upside)
Technical Analysis
---